Corrigendum: Repurposing the Chemical Scaffold of the Anti‐Arthritic Drug Lobenzarit to Target Tryptophan Biosynthesis in Mycobacterium tuberculosis

Publisher： John Wiley & Sons Inc

ISSN： 1439-4227

Source： CHEMBIOCHEM, Vol.16, Iss.5, 2015-03, pp. : 706-706

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-arthritic activity of various extracts of Sida rhombifolia aerial parts

By Gupta S. R.  

Natural Product Research, Vol. 23, Iss. 8, 2009-01 ,pp. : 689-695

Taylor & Francis Ltd

Access to resources Recommend Favorite

An Antibacterial β‐Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 57, Iss. 1, 2018-01 ,pp. : 348-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections

By  

ADVANCED HEALTHCARE MATERIALS (ELECTRONIC), Vol. 7, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Toward Drug Repurposing in Epigenetics: Olsalazine as a Hypomethylating Compound Active in a Cellular Context

By  

CHEMMEDCHEM, Vol. 9, Iss. 3, 2014-03 ,pp. : 560-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Forward Chemical Genetics: Library Scaffold Design

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 7, Iss. 7, 2004-11 ,pp. : 645-652

Bentham Science Publishers

Access to resources Recommend Favorite